From what I can gather, the biological classification is in the same subset as device. While it means a little bit more work than pure 'device' (which is not a problem) it is far far far better than being a pharmaceutical and facing phase 1, 2 & 3 trials.
- Forums
- ASX - By Stock
- TIS
- success
success, page-28
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online